The 7th Annual Drug Discovery for Neurodegeneration Conference course is designed to advance the development of new drugs for neurodegenerative diseases by educating scientists on the principles and practice of drug discovery, including topics such as high throughput screening, lead optimization, preclinical proof-of-concept, and IND enabling and regulator issues. The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.